Tim

Powell

Senior Counsel

praised as “an IP legend” who possesses “an excellent commercial perspective” when it comes to dispute resolution.

Who’s Who Legal

Tim

Powell

Senior Counsel

praised as “an IP legend” who possesses “an excellent commercial perspective” when it comes to dispute resolution.

Who’s Who Legal

Profile

Tim has a strong technical background that has enabled him to represent clients in some of the largest and most complex intellectual property disputes to come before the UK courts in recent years.

Tim specialises in multi-jurisdictional litigation, particularly in the patents field where he has experience in coordinating litigation taking place simultaneously across Europe, North America and beyond.

He is a solicitor advocate and has represented clients as an advocate in the UK and European Patent Offices, the English High Court, Court of Appeal, House of Lords and the European Court of Justice.

This breadth of expertise means that Tim often lectures on all aspects of IP law.

Tim is available to act as an arbitrator in IP disputes and is on the list of Neutrals of the WIPO Arbitration and Mediation Centre as an expert specialised in life sciences.

Tim was one of the founding partners of Powell Gilbert LLP in 2007.

Key cases

  • Illumina v MGI (gene sequencing technology)
  • Abbott v Edwards Lifesciences (transcatheter mitral valve repair)
  • GlaxoSmithKline v Fibrogen & Astellas(anaemia therapeutics)
  • Chugai Pharmaceutical v UCB (patent licence dispute – antibody technology)
  • Accord Healthcare v Research Corporation Technologies (anti-epileptics)
  • ​Leonardo MW v Elbit Systems(missile defence systems)
  • Illumina v Ariosa & Premaitha (non-invasive pre-natal testing)
  • ​Edwards Lifesciences v Boston Scientific (transcatheter heart valves)
  • Warner-Lambert v Actavis & Others(pregabalin)
  • Vringo v ZTE(telecommunications / FRAND licensing)
  • Actavis v Sanofi Aventis(SPCs – irbesartan combinations)
  • Apple v Nokia(smartphones)
  • Microsoft v Motorola Mobility(smartphones)
  • Yeda v Sanofi Aventis and ImClone(monoclonal antibodies)
  • Cisco Systems v Comptel(software licence dispute)
  • Affymetrix v Multilyte(DNA microarrays)
  • Mölnlycke v BSN(wound dressings)
  • Philips v Princo(CD-R technology)
  • Monsanto v Cargill(GM crops)
  • Pharmacia v Merck(Cox 2 inhibitors)
  • Chiron v Murex and Others(HCV)

 

Qualifications

1990 Solicitor (England & Wales)

2004 Solicitor Advocate (England & Wales)

2022 Solicitor (Ireland)

Education

MA (Natural Sciences), Cambridge University

Diploma in Intellectual Property Law and Practice, Bristol University

Connections & Networks

Member of AIPPI and EPLAW

Awards & Recognition

IAM Global Leader (2023, 2021)

Legal 500 – Hall of Fame (2022, 2021, 2020)

LMG European Life Sciences Awards: IP Lawyer of the Year: Medical devices (2021,2022)

Who’s Who Legal Patents and Life Sciences Global Elite Thought Leader (2023, 2022, 2021, 2020, 2019, 2018)

IAM Patent 1000: UK Patent Litigation (Gold Tier)

Managing IP’s IP Stars – Patent Star

Juve Patent – Leading Individual, Patent Litigation UK

World IP Review – Leader

Leaders League, Innovation – Technology & IP – Leading Partners

Top 100 business lawyers in the UK in the “Chambers 100” (2013)

Top 100 London SuperLawyers (2015)

Additional Facts
Favourite technology

I have a particular interest in life sciences ranging from medical technology to biotech

Additional Facts
Interests

I am currently preparing a boat for a transatlantic crossing with my family

Additional Facts
Life before law

After University, I worked on a marine research station studying tropical marine ecology